Search research articles
Contact Us
Filters
Showing results (231-240 of 248) with videos related to
Page
of 25
Sort By:
Frontiers in Immunology
|
June 17, 2017
Notch Regulates Macrophage-Mediated Inflammation in Diabetic Wound Healing
Andrew S Kimball, Amrita D Joshi, Anna E Boniakowski, et al.
Gynecologic Oncology
|
November 27, 2016
The effect of photobiomodulation on chemotherapy-induced peripheral neuropathy: A randomized, sham-controlled clinical trial
Peter A Argenta, Karla V Ballman, Melissa A Geller, et al.
Diabetes
|
July 1, 2017
The Histone Methyltransferase MLL1 Directs Macrophage-Mediated Inflammation in Wound Healing and Is Altered in a Murine Model of Obesity and Type 2 Diabetes
Andrew S Kimball, Amrita Joshi, William F Carson, et al.
Cancer
|
December 7, 2007
A prospective randomized trial of thalidomide with topotecan compared with topotecan alone in women with recurrent epithelial ovarian carcinoma
Levi S Downs, Patricia L Judson, Peter A Argenta, et al.
Blood
|
February 5, 2010
The post sepsis-induced expansion and enhanced function of regulatory T cells create an environment to potentiate tumor growth
Karen A Cavassani, William F Carson, Ana Paula Moreira, et al.
Plos One
|
September 3, 2010
Delta-like 4 differentially regulates murine CD4 T cell expansion via BMI1
Matthew A Schaller, Hannah Logue, Sumanta Mukherjee, et al.
Blood
|
July 2, 2009
Epigenetic regulation of the alternatively activated macrophage phenotype
Makoto Ishii, Haitao Wen, Callie A S Corsa, et al.
Plos One
|
November 9, 2013
Cytokine induced phenotypic and epigenetic signatures are key to establishing specific macrophage phenotypes
Nicolai A Kittan, Ronald M Allen, Abhay Dhaliwal, et al.
American Journal of Respiratory and Critical Care Medicine
|
October 3, 2009
Toll-like receptor 9 activation is a key mechanism for the maintenance of chronic lung inflammation
Toshihiro Ito, Matthew Schaller, Tracy Raymond, et al.
Cytotherapy
|
September 21, 2010
A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer
Melissa A Geller, Sarah Cooley, Patricia L Judson, et al.
Page
of 25
Search research articles
Search
Showing results (231-240 of 248) with videos related to
Sort By:
Page
of 25
Frontiers in Immunology
|
June 17, 2017
Notch Regulates Macrophage-Mediated Inflammation in Diabetic Wound Healing
Andrew S Kimball, Amrita D Joshi, Anna E Boniakowski, et al.
Gynecologic Oncology
|
November 27, 2016
The effect of photobiomodulation on chemotherapy-induced peripheral neuropathy: A randomized, sham-controlled clinical trial
Peter A Argenta, Karla V Ballman, Melissa A Geller, et al.
Diabetes
|
July 1, 2017
The Histone Methyltransferase MLL1 Directs Macrophage-Mediated Inflammation in Wound Healing and Is Altered in a Murine Model of Obesity and Type 2 Diabetes
Andrew S Kimball, Amrita Joshi, William F Carson, et al.
Cancer
|
December 7, 2007
A prospective randomized trial of thalidomide with topotecan compared with topotecan alone in women with recurrent epithelial ovarian carcinoma
Levi S Downs, Patricia L Judson, Peter A Argenta, et al.
Blood
|
February 5, 2010
The post sepsis-induced expansion and enhanced function of regulatory T cells create an environment to potentiate tumor growth
Karen A Cavassani, William F Carson, Ana Paula Moreira, et al.
Plos One
|
September 3, 2010
Delta-like 4 differentially regulates murine CD4 T cell expansion via BMI1
Matthew A Schaller, Hannah Logue, Sumanta Mukherjee, et al.
Blood
|
July 2, 2009
Epigenetic regulation of the alternatively activated macrophage phenotype
Makoto Ishii, Haitao Wen, Callie A S Corsa, et al.
Plos One
|
November 9, 2013
Cytokine induced phenotypic and epigenetic signatures are key to establishing specific macrophage phenotypes
Nicolai A Kittan, Ronald M Allen, Abhay Dhaliwal, et al.
American Journal of Respiratory and Critical Care Medicine
|
October 3, 2009
Toll-like receptor 9 activation is a key mechanism for the maintenance of chronic lung inflammation
Toshihiro Ito, Matthew Schaller, Tracy Raymond, et al.
Cytotherapy
|
September 21, 2010
A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer
Melissa A Geller, Sarah Cooley, Patricia L Judson, et al.
Page
of 25